Deprotection and Purification of Oligonucleotides

CF Chantal M. Ferguson
DE Dimas Echeverria
MH Matthew Hassler
SL Socheata Ly
AK Anastasia Khvorova
request Request a Protocol
ask Ask a question
Favorite

All oligonucleotides were cleaved and deprotected using ammonium hydroxide and 40% aqueous (aq.) methylamine (AMA) in a 1:1 ratio for 2 h at room temperature. The oligonucleotide solutions were then filtered to remove the CPG from the cleaved oligo. The filtrate was then cooled with dry ice and then dried under vacuum in a SpeedVac. The resulting pellets were resuspended in 5% ACN in water. The purification of the unconjugated strands were performed on an Agilent 1200 system, equipped with a Source 15Q anion exchange resin (GE Healthcare; 10 × 100 mm custom-packed column), using the following conditions: eluent A, 20% ACN, 20  mM sodium acetate (pH 5); eluent B, 1 M sodium perchlorate in 20% ACN; gradient, 0% B 2 min, 35% B 12  min, clean, and re-equilibration to initial conditions 6 min. Purification of cholesterol-conjugated strands was performed on the same equipment but equipped with a PRP-C18 (Hamilton), a polymer reverse-phase column (10 × 100 mm), using the following conditions: eluent A, 50 mM sodium acetate in 5% ACN; eluent B, ACN; gradient, 0% B 2 min, 0%–40% B 1 min, 40%–70% B 9 min, clean, and re-equilibration 6 min. Temperature 70 °C and flow rate 40 mL/min were the same in both cases. Peaks were monitored at 260 nm. The pure oligonucleotide fractions were collected, individually characterized by liquid chromatography-mass spectrometry (LC-MS), combined, frozen, and dried in a SpeedVac overnight. Oligonucleotides were resuspended in 5% ACN and desalted through fine Sephadex G-25 (GE Healthcare; 10 × 200 mm custom-packed column) and lyophilized. All reagents mentioned above were purchased from Sigma-Aldrich and used as per the manufacturer’s instructions, unless otherwise stated.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A